Pub Date : 2000-01-01DOI: 10.1177/155005940003100111
M B Sterman
Two issues concerning sensorimotor EEG operant conditioning, or biofeedback, as a therapeutic modality for the treatment of seizure disorders are the focus of this review. The first relates to the question of whether relevant physiological changes are associated with this procedure. This question is addressed through review of an extensive neurophysiological literature that is likely unfamiliar to many clinicians but that documents both immediate and sustained functional changes that are consistent with elevation of seizure thresholds. The second focuses on the clinical efficacy of this method and whether it should carry the designation of "experimental". This designation is challenged through an assessment of over 25 years of peer-reviewed research demonstrating impressive EEG and clinical results achieved with the most difficult subset of seizure patients.
{"title":"Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning.","authors":"M B Sterman","doi":"10.1177/155005940003100111","DOIUrl":"https://doi.org/10.1177/155005940003100111","url":null,"abstract":"<p><p>Two issues concerning sensorimotor EEG operant conditioning, or biofeedback, as a therapeutic modality for the treatment of seizure disorders are the focus of this review. The first relates to the question of whether relevant physiological changes are associated with this procedure. This question is addressed through review of an extensive neurophysiological literature that is likely unfamiliar to many clinicians but that documents both immediate and sustained functional changes that are consistent with elevation of seizure thresholds. The second focuses on the clinical efficacy of this method and whether it should carry the designation of \"experimental\". This designation is challenged through an assessment of over 25 years of peer-reviewed research demonstrating impressive EEG and clinical results achieved with the most difficult subset of seizure patients.</p>","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"31 1","pages":"45-55"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/155005940003100111","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The state of EEG biofeedback therapy (EEG operant conditioning) in 2000: an editor's opinion.","authors":"F H Duffy","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"31 1","pages":"V-VII"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2000-01-01DOI: 10.1177/155005940003100106
J P Rosenfeld
INTRODUCTION Despite our own older work which showed that biofeedback with somatosensory evoked EEG potentials can have profound effects on pain perception in rats and it seemed to us quite a leap to think that an application of EEG biofeedback could be effective in treatment of depression and other affective disorders. Yet the logic of developing such an intervention would be no different than that which was used in our work in the pain modality: In that work, we were aware of-a sizable literature documenting evoked EEG potential (EP) correlates of We reasoned simply that if a large value of a particular EP component accompanied intense pain, whereas a smaller value accompanied no pain or analgesia, then if one could train individuals to reduce the particular EP, one ought to see reductions in perceived pain. This approach yielded very promising Thus it seemed to us that a reliable EEG index of affect could be found, then we would be in a position to develop an EEG biofeedback protocol for depression. However, until the relatively recent publication of work from R. J. Davidson's laboratory,g there were no documented reliable indices of affect in the waking EEG. Based on evidence from the neurology literature, Davidson and associates hypothesized that the right frontal cortex contained a neural system mediating negative emotion and avoidance behavior, whereas, in contrast, the left frontal cortex contained a neural system mediating positive affect and approach behavior. An active cortex is known to show higher (13-30 Hz) "beta" frequencies in a low amplitude, desynchronized EEG, whereas an idling or inactive cortex is known to show lower (8-12 Hz) "alpha" frequencies of synchronous (sinusoidal) higher amplitude activity. Davidson and colleagues thus hypothesized that positive emotion should correlate with high beta and low alpha activity in the left frontal cortex and with low beta and high alpha activity in the right frontal cortex. Negative emotion would correlate with the reverse pattern of cortical activity: high left frontal alpha, low lefi frontal beta, high right frontal beta, and low right frontal alpha. Because there are harmonics of electromyographic activity reaching down to the beta range, which could be therefore mistaken as beta, many researchers have focused on the alpha (inverse) indices of emotion. (It is possible to utilize beta, but it requires added steps to correct for electromyographic artifact.) In a series of ingenious, original experiments, Davidson and colleagues provided a strong set of evidence that cortical activation asymmetry as inversely indexed by alpha power or magnitude, was a reliable correlate of positive and negative emotion. The asymmetry metric developed by the Davidson group will be referred to here as the asymmetry score =A, = log R log L where R is alpha power at cortical site F, and L is alpha power at cortical site F, . It is also possible to define an asymmetry score as A, = (R-URtL). Although A, and
{"title":"An EEG biofeedback protocol for affective disorders.","authors":"J P Rosenfeld","doi":"10.1177/155005940003100106","DOIUrl":"https://doi.org/10.1177/155005940003100106","url":null,"abstract":"INTRODUCTION Despite our own older work which showed that biofeedback with somatosensory evoked EEG potentials can have profound effects on pain perception in rats and it seemed to us quite a leap to think that an application of EEG biofeedback could be effective in treatment of depression and other affective disorders. Yet the logic of developing such an intervention would be no different than that which was used in our work in the pain modality: In that work, we were aware of-a sizable literature documenting evoked EEG potential (EP) correlates of We reasoned simply that if a large value of a particular EP component accompanied intense pain, whereas a smaller value accompanied no pain or analgesia, then if one could train individuals to reduce the particular EP, one ought to see reductions in perceived pain. This approach yielded very promising Thus it seemed to us that a reliable EEG index of affect could be found, then we would be in a position to develop an EEG biofeedback protocol for depression. However, until the relatively recent publication of work from R. J. Davidson's laboratory,g there were no documented reliable indices of affect in the waking EEG. Based on evidence from the neurology literature, Davidson and associates hypothesized that the right frontal cortex contained a neural system mediating negative emotion and avoidance behavior, whereas, in contrast, the left frontal cortex contained a neural system mediating positive affect and approach behavior. An active cortex is known to show higher (13-30 Hz) \"beta\" frequencies in a low amplitude, desynchronized EEG, whereas an idling or inactive cortex is known to show lower (8-12 Hz) \"alpha\" frequencies of synchronous (sinusoidal) higher amplitude activity. Davidson and colleagues thus hypothesized that positive emotion should correlate with high beta and low alpha activity in the left frontal cortex and with low beta and high alpha activity in the right frontal cortex. Negative emotion would correlate with the reverse pattern of cortical activity: high left frontal alpha, low lefi frontal beta, high right frontal beta, and low right frontal alpha. Because there are harmonics of electromyographic activity reaching down to the beta range, which could be therefore mistaken as beta, many researchers have focused on the alpha (inverse) indices of emotion. (It is possible to utilize beta, but it requires added steps to correct for electromyographic artifact.) In a series of ingenious, original experiments, Davidson and colleagues provided a strong set of evidence that cortical activation asymmetry as inversely indexed by alpha power or magnitude, was a reliable correlate of positive and negative emotion. The asymmetry metric developed by the Davidson group will be referred to here as the asymmetry score =A, = log R log L where R is alpha power at cortical site F, and L is alpha power at cortical site F, . It is also possible to define an asymmetry score as A, = (R-URtL). Although A, and ","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"31 1","pages":"7-12"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/155005940003100106","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2000-01-01DOI: 10.1177/155005940003100109
J K Nash
Significant public health concerns exist regarding our current level of success in treating ADHD. Medication management is very helpful in 60-70% of patients. Side effects, lack of compliance and the fact that stimulant medications cannot be given late in the day limit the benefits largely to school hours. While stimulants improve behavior and attention, less of an effect has been noted on academic and social performance. Continuing concerns exist about long-term safety, and studies on long-term cardiovascular and neurophysiological effects have not been carried out. Neurotherapy for ADHD offers an effective alternate for patients whose treatment is limited by side effects, poor medication response and in cases in which the patients and/or their parents refuse to consider medications. Studies indicate clinical improvement is largely related to measurable improvements in the EEG signature, evidenced by declining theta/beta ratios over frontal/central cortex and/or reduced theta/alpha band amplitudes.
{"title":"Treatment of attention deficit hyperactivity disorder with neurotherapy.","authors":"J K Nash","doi":"10.1177/155005940003100109","DOIUrl":"https://doi.org/10.1177/155005940003100109","url":null,"abstract":"<p><p>Significant public health concerns exist regarding our current level of success in treating ADHD. Medication management is very helpful in 60-70% of patients. Side effects, lack of compliance and the fact that stimulant medications cannot be given late in the day limit the benefits largely to school hours. While stimulants improve behavior and attention, less of an effect has been noted on academic and social performance. Continuing concerns exist about long-term safety, and studies on long-term cardiovascular and neurophysiological effects have not been carried out. Neurotherapy for ADHD offers an effective alternate for patients whose treatment is limited by side effects, poor medication response and in cases in which the patients and/or their parents refuse to consider medications. Studies indicate clinical improvement is largely related to measurable improvements in the EEG signature, evidenced by declining theta/beta ratios over frontal/central cortex and/or reduced theta/alpha band amplitudes.</p>","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"31 1","pages":"30-7"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/155005940003100109","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2000-01-01DOI: 10.1177/155005940003100107
D L Trudeau
INTRODUCTION This paper is presented as one of a series of papers in a focal issue of Clinical EEG describing and reviewing clinical brain wave biofeedback. The objective of this paper is to review the reported work on EEG biofeedback in Psychoactive Substance Use Disorder (PSUD) to date, the critical studies that have been undertaken. and to suggest further research directions. In the latter, the paper does not purport to offer the last word on possibilities for future research of EEG biofeedback and PSUD, but will make some contributions to that ongoing dialogue. This paper will give some mention of two other disorders featured in this issue, attention deficit hyperactivity disorder (ADHD) and traumatic brain injury (TBI), as important comorbidities in terms of their confounding impact on brain wave biofeedback of PSUD. No attempt will be made to review the field of biofeedback or of addictive disorders generally, although references will be made to specifics that are pertinent to a discussion of some emerging concepts of EEG biofeedback as a treatment for PSUD. In reviewing the findings reported to date on the use and effectiveness of EEG biofeedback in the treatment of PSUD, one is hampered by the paucity of published studies. Unfortunately, large controlled multi-center studies have yet to be reported, and a review of the existing literature is limited to case studies, open clinical trials and a few small controlled and randomized studies mainly focused on alpha-theta feedback. This paper will summarize those reports, as well as reports from several controlled placebo condition studies that have focused on assessing the specificity of alpha-theta to therapeutic effect. Before there is wide acceptance of brain wave biofeedback clinically, much more research is needed. In research design, the existing broad literature on outcome assessment of PSUD and PSUD psychiatric comorbidity needs to be taken into account. This paper will not attempt to review the literature generally related to outcome design and comorbidity, but will focus on specifics from these areas related to brain wave biofeedback study design. As discussed in the following sections, brain wave biofeedback was originally conceptualized as a way to augment insight and motivation through guided imagery in alcoholics, and the focus of initial implementation was on achieving very relaxed hypnagogic states using occipital slow wave feedback. However, much information has come to the fore regarding specific EEG aberrations in PSUD. It is beyond the scope of this paper to review the voluminous literature on EEG and QEEG in PSUD. However, several QEEG studies point to very specific abnormalities likely associated with drug neurotoxicity, suggesting that specific EEG biofeedback protocols may be studied for effect on these conditions. This is especially so in light of the potential for EEG biofeedback to address neurologically based problems such as TBI and ADHD that also may be associated
{"title":"The treatment of addictive disorders by brain wave biofeedback: a review and suggestions for future research.","authors":"D L Trudeau","doi":"10.1177/155005940003100107","DOIUrl":"https://doi.org/10.1177/155005940003100107","url":null,"abstract":"INTRODUCTION This paper is presented as one of a series of papers in a focal issue of Clinical EEG describing and reviewing clinical brain wave biofeedback. The objective of this paper is to review the reported work on EEG biofeedback in Psychoactive Substance Use Disorder (PSUD) to date, the critical studies that have been undertaken. and to suggest further research directions. In the latter, the paper does not purport to offer the last word on possibilities for future research of EEG biofeedback and PSUD, but will make some contributions to that ongoing dialogue. This paper will give some mention of two other disorders featured in this issue, attention deficit hyperactivity disorder (ADHD) and traumatic brain injury (TBI), as important comorbidities in terms of their confounding impact on brain wave biofeedback of PSUD. No attempt will be made to review the field of biofeedback or of addictive disorders generally, although references will be made to specifics that are pertinent to a discussion of some emerging concepts of EEG biofeedback as a treatment for PSUD. In reviewing the findings reported to date on the use and effectiveness of EEG biofeedback in the treatment of PSUD, one is hampered by the paucity of published studies. Unfortunately, large controlled multi-center studies have yet to be reported, and a review of the existing literature is limited to case studies, open clinical trials and a few small controlled and randomized studies mainly focused on alpha-theta feedback. This paper will summarize those reports, as well as reports from several controlled placebo condition studies that have focused on assessing the specificity of alpha-theta to therapeutic effect. Before there is wide acceptance of brain wave biofeedback clinically, much more research is needed. In research design, the existing broad literature on outcome assessment of PSUD and PSUD psychiatric comorbidity needs to be taken into account. This paper will not attempt to review the literature generally related to outcome design and comorbidity, but will focus on specifics from these areas related to brain wave biofeedback study design. As discussed in the following sections, brain wave biofeedback was originally conceptualized as a way to augment insight and motivation through guided imagery in alcoholics, and the focus of initial implementation was on achieving very relaxed hypnagogic states using occipital slow wave feedback. However, much information has come to the fore regarding specific EEG aberrations in PSUD. It is beyond the scope of this paper to review the voluminous literature on EEG and QEEG in PSUD. However, several QEEG studies point to very specific abnormalities likely associated with drug neurotoxicity, suggesting that specific EEG biofeedback protocols may be studied for effect on these conditions. This is especially so in light of the potential for EEG biofeedback to address neurologically based problems such as TBI and ADHD that also may be associated ","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"31 1","pages":"13-22"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/155005940003100107","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2000-01-01DOI: 10.1177/155005940003100108
J Gruzelier
Contrary to the belief that schizophrenic patients will be unable to learn self control of electrocortical activity due to attentional and motivational deficits, the two studies which have investigated this, both involving operant conditioning of slow cortical potentials, have demonstrated that self regulation can take place. This was particularly true of a study of interhemispheric control. Learning difficulties were found to be more to do with sustaining motivation towards the end of sessions or training programs, rather than in initial learning. Schizotypical features in the normal population have in the case of anhedonia been associated with slower learning, while withdrawn introversion has been associated with faster learning. In view of the affirmative evidence and advances in understanding the functional significance of electroencephalographic (EEG) rhythms, the undertaking of therepeutic regimens with electrocortical operant conditioning is warranted in the schizophrenia spectrum.
{"title":"Self regulation of electrocortical activity in schizophrenia and schizotypy: a review.","authors":"J Gruzelier","doi":"10.1177/155005940003100108","DOIUrl":"https://doi.org/10.1177/155005940003100108","url":null,"abstract":"<p><p>Contrary to the belief that schizophrenic patients will be unable to learn self control of electrocortical activity due to attentional and motivational deficits, the two studies which have investigated this, both involving operant conditioning of slow cortical potentials, have demonstrated that self regulation can take place. This was particularly true of a study of interhemispheric control. Learning difficulties were found to be more to do with sustaining motivation towards the end of sessions or training programs, rather than in initial learning. Schizotypical features in the normal population have in the case of anhedonia been associated with slower learning, while withdrawn introversion has been associated with faster learning. In view of the affirmative evidence and advances in understanding the functional significance of electroencephalographic (EEG) rhythms, the undertaking of therepeutic regimens with electrocortical operant conditioning is warranted in the schizophrenia spectrum.</p>","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"31 1","pages":"23-9"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/155005940003100108","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2000-01-01DOI: 10.1177/155005940003100110
R W Thatcher
A review is presented of the currently sparse literature about EEG operant conditioning or biofeedback as a treatment to reduce symptomology and patient complaints following a traumatic brain injury. The paper also evaluates the general use of quantitative EEG (QEEG) to assess traumatic brain injury and to facilitate EEG biofeedback treatment. The use of an age matched reference normative QEEG database and QEEG discriminant function are presented as a method to evaluate the nature or neurological basis of a patient's complaints as well as to individualize an efficient and optimal feedback protocol and to help evaluate the efficacy of the biofeedback therapy. Univariate and multivariate statistical issues are discussed, different classes of experimental designs are described and then a "double blind" research study is proposed in an effort to encourage future research in the area of EEG biofeedback for the treatment and rehabilitation of traumatic brain injury.
{"title":"EEG operant conditioning (biofeedback) and traumatic brain injury.","authors":"R W Thatcher","doi":"10.1177/155005940003100110","DOIUrl":"https://doi.org/10.1177/155005940003100110","url":null,"abstract":"<p><p>A review is presented of the currently sparse literature about EEG operant conditioning or biofeedback as a treatment to reduce symptomology and patient complaints following a traumatic brain injury. The paper also evaluates the general use of quantitative EEG (QEEG) to assess traumatic brain injury and to facilitate EEG biofeedback treatment. The use of an age matched reference normative QEEG database and QEEG discriminant function are presented as a method to evaluate the nature or neurological basis of a patient's complaints as well as to individualize an efficient and optimal feedback protocol and to help evaluate the efficacy of the biofeedback therapy. Univariate and multivariate statistical issues are discussed, different classes of experimental designs are described and then a \"double blind\" research study is proposed in an effort to encourage future research in the area of EEG biofeedback for the treatment and rehabilitation of traumatic brain injury.</p>","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"31 1","pages":"38-44"},"PeriodicalIF":0.0,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/155005940003100110","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21493696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1999-10-01DOI: 10.1177/155005949903000409
D L Trudeau, P Thuras, H Stockley
QEEG was studied in a population of chronic male PSUD/ADHD (psychoactive substance use disorder/attention deficit hyperactivity disorder) subjects vs. a matched sample of non-ADHD subjects with PSUD. Our first interest in conducting this study was to determine if the Thatcher University of Maryland database and complex demodulation method could replicate the specific QEEG findings reported for cocaine and cannabis using the John-NYU database and Fourier Transform method. The effects of cannabis and stimulants were also studied both separately and together to see if there were interactions and to see if the QEEG changes associated with chronic stimulant dependence were predicted by childhood ADHD status. Eyes-closed QEEGs were obtained and two independent artifacted 60 second samples were compared for reliability. The Thatcher database was used to analyze QEEG data from 56 subjects with mixed substance use disorder. Results showed that the Thatcher database replicates the John database for chronic stimulant dependence findings. Because of confounding variables of alcohol and polysubstance abuse, the findings related to cannabis and stimulant interaction were difficult to assess. Cannabis and stimulant dependence together produced more QEEG changes than either alone. More right temporal abnormalities were observed with stimulant dependence. In the absence of stimulant use, the QEEG effects of cannabis were relatively small; however, sample selection and methods used precluded comparison to previous studies. The persistent QEEG abnormalities associated with chronic stimulant dependence were independent of ADHD status in this sample using the methods of this study. Further research is needed to clarify the relationship of stimulant dependence with QEEG changes and ADHD status, and to clarify the interactions of chronic stimulant and cannabis abuse on QEEG.
{"title":"Quantitative EEG findings associated with chronic stimulant and cannabis abuse and ADHD in an adult male substance use disorder population.","authors":"D L Trudeau, P Thuras, H Stockley","doi":"10.1177/155005949903000409","DOIUrl":"https://doi.org/10.1177/155005949903000409","url":null,"abstract":"<p><p>QEEG was studied in a population of chronic male PSUD/ADHD (psychoactive substance use disorder/attention deficit hyperactivity disorder) subjects vs. a matched sample of non-ADHD subjects with PSUD. Our first interest in conducting this study was to determine if the Thatcher University of Maryland database and complex demodulation method could replicate the specific QEEG findings reported for cocaine and cannabis using the John-NYU database and Fourier Transform method. The effects of cannabis and stimulants were also studied both separately and together to see if there were interactions and to see if the QEEG changes associated with chronic stimulant dependence were predicted by childhood ADHD status. Eyes-closed QEEGs were obtained and two independent artifacted 60 second samples were compared for reliability. The Thatcher database was used to analyze QEEG data from 56 subjects with mixed substance use disorder. Results showed that the Thatcher database replicates the John database for chronic stimulant dependence findings. Because of confounding variables of alcohol and polysubstance abuse, the findings related to cannabis and stimulant interaction were difficult to assess. Cannabis and stimulant dependence together produced more QEEG changes than either alone. More right temporal abnormalities were observed with stimulant dependence. In the absence of stimulant use, the QEEG effects of cannabis were relatively small; however, sample selection and methods used precluded comparison to previous studies. The persistent QEEG abnormalities associated with chronic stimulant dependence were independent of ADHD status in this sample using the methods of this study. Further research is needed to clarify the relationship of stimulant dependence with QEEG changes and ADHD status, and to clarify the interactions of chronic stimulant and cannabis abuse on QEEG.</p>","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"30 4","pages":"165-74"},"PeriodicalIF":0.0,"publicationDate":"1999-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/155005949903000409","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21376037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1999-10-01DOI: 10.1177/155005949903000410
D L Sherman, A M Brambrink, R N Ichord, V K Dasika, R C Koehler, R J Traystman, D F Hanley, N V Thakor
This study examined the course of EEG recovery in an animal model of hypoxic-ischemic injury. The model used periods of hypoxia, room air and asphyxia to induce cardiac arrest. One-week-old piglets (n = 16) were exposed to a period of hypoxia, room air and complete asphyxia for 7 minutes. After cardiac arrest and resuscitation, two EEG features were evaluated as prognostic indicators of behavioral outcome as assessed by a neuroscore at 24 hours after insult. A prominent EEG feature was the number and duration of bursts evident during recovery. Episodes of bursting were detected through the thresholds on sustained periods of elevated power. After the animal was resuscitated, the EEG was monitored continuously for 4 hours. To assess outcome in the recovering animal, a behavioral testing scale was used to test the animal's neurological capabilities. Trends of EEG burst counts were measured through thresholds on sustained power changes. Bursts are energy transients in the EEG record. High degrees of bursting were characteristic of animals having good neurological condition whereas piglets having low burst counts had poor 24 hr neuroscores. At 100 min the average burst rate of the good neuroscore outcome group was more than 8 per min and was significantly different from the poor outcome group's level of 2.7 (p < or = 0.05). When these counts were weighted by their total duration, differences between groups increased (p < or = 0.02). This study showed that the QEEG measure of burst counts and duration together provided a strong prognostic indication of the 24 hour outcome after asphyxic injury in a neonatal animal model. The critical determinant of the bursting character was the time when bursting occurred. Bursting occurring early in recovery was a good gauge of outcome. We conclude that quantitative EEG analysis and interpretation can be an important tool for the outcome determination during recovery from cerebral injury states.
{"title":"Quantitative EEG during early recovery from hypoxic-ischemic injury in immature piglets: burst occurrence and duration.","authors":"D L Sherman, A M Brambrink, R N Ichord, V K Dasika, R C Koehler, R J Traystman, D F Hanley, N V Thakor","doi":"10.1177/155005949903000410","DOIUrl":"https://doi.org/10.1177/155005949903000410","url":null,"abstract":"<p><p>This study examined the course of EEG recovery in an animal model of hypoxic-ischemic injury. The model used periods of hypoxia, room air and asphyxia to induce cardiac arrest. One-week-old piglets (n = 16) were exposed to a period of hypoxia, room air and complete asphyxia for 7 minutes. After cardiac arrest and resuscitation, two EEG features were evaluated as prognostic indicators of behavioral outcome as assessed by a neuroscore at 24 hours after insult. A prominent EEG feature was the number and duration of bursts evident during recovery. Episodes of bursting were detected through the thresholds on sustained periods of elevated power. After the animal was resuscitated, the EEG was monitored continuously for 4 hours. To assess outcome in the recovering animal, a behavioral testing scale was used to test the animal's neurological capabilities. Trends of EEG burst counts were measured through thresholds on sustained power changes. Bursts are energy transients in the EEG record. High degrees of bursting were characteristic of animals having good neurological condition whereas piglets having low burst counts had poor 24 hr neuroscores. At 100 min the average burst rate of the good neuroscore outcome group was more than 8 per min and was significantly different from the poor outcome group's level of 2.7 (p < or = 0.05). When these counts were weighted by their total duration, differences between groups increased (p < or = 0.02). This study showed that the QEEG measure of burst counts and duration together provided a strong prognostic indication of the 24 hour outcome after asphyxic injury in a neonatal animal model. The critical determinant of the bursting character was the time when bursting occurred. Bursting occurring early in recovery was a good gauge of outcome. We conclude that quantitative EEG analysis and interpretation can be an important tool for the outcome determination during recovery from cerebral injury states.</p>","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"30 4","pages":"175-83"},"PeriodicalIF":0.0,"publicationDate":"1999-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/155005949903000410","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21376038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1999-10-01DOI: 10.1177/155005949903000408
C Machado
A new formulation of death proposed in this study is based on the basic physiopathological mechanisms of consciousness generation in human beings. Two physiological components control conscious behavior: arousal and awareness (content of consciousness). We cannot simply differentiate and locate arousal as a function of the ascending reticular activating system and awareness as a function of the cerebral cortex. Substantial interconnections among the brainstem, subcortical structures and the neocortex, are essential for subserving and integrating both components of human consciousness. Therefore, consciousness does not bear a simple one-to-one relationship with higher or lower brain structures, because the physical substratum for consciousness is based on anatomy and physiology throughout the brain. This new account of human death is based on the irreversible loss of consciousness because it provides the key human attributes and the highest level of control in the hierarchy of integrating functions within the organism. The notion of consciousness as the ultimate integrative function is more consistent with the biologically-based systems than the more philosophically-based notions of personhood.
{"title":"Consciousness as a definition of death: its appeal and complexity.","authors":"C Machado","doi":"10.1177/155005949903000408","DOIUrl":"https://doi.org/10.1177/155005949903000408","url":null,"abstract":"<p><p>A new formulation of death proposed in this study is based on the basic physiopathological mechanisms of consciousness generation in human beings. Two physiological components control conscious behavior: arousal and awareness (content of consciousness). We cannot simply differentiate and locate arousal as a function of the ascending reticular activating system and awareness as a function of the cerebral cortex. Substantial interconnections among the brainstem, subcortical structures and the neocortex, are essential for subserving and integrating both components of human consciousness. Therefore, consciousness does not bear a simple one-to-one relationship with higher or lower brain structures, because the physical substratum for consciousness is based on anatomy and physiology throughout the brain. This new account of human death is based on the irreversible loss of consciousness because it provides the key human attributes and the highest level of control in the hierarchy of integrating functions within the organism. The notion of consciousness as the ultimate integrative function is more consistent with the biologically-based systems than the more philosophically-based notions of personhood.</p>","PeriodicalId":75713,"journal":{"name":"Clinical EEG (electroencephalography)","volume":"30 4","pages":"156-64"},"PeriodicalIF":0.0,"publicationDate":"1999-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/155005949903000408","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21376036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}